Now that Eli Lilly & Co.'s antidepressant Cymbalta and some other blockbusters have gone generic, the company is spending less on promotional activities by doctors.
March 4, 2014 The sharp decline in payments coincides with increased scrutiny of drug marketing. Later this year, federal law will also require that drugmakers disclose the amount of money they give to doctors.
<iframe src="http://www.npr.org/player/embed/285298999/285581493" width="100%" height="290" frameborder="0" scrolling="no">
NPR thanks our sponsors
Become an NPR sponsor